Skip to content
Home/Companies/Healthcare / Medtech/ReCor Medical

ReCor Medical

Healthcare / Medtech·US·Exited 2018·Held 2yr
Entry
2016
Hold
2yr
Exit
2018

Who owns ReCor Medical?

ReCor Medical was owned by Sofinnova Partners through Sofinnova Capital VIII (2015 vintage) from 2016 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VIII · 2015 · Life Sciences VC

Key facts

HQUnited States
SectorHealthcare / Medtech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

VectivBio
Exited 2023
BiotechSwitzerland· 2017
to
Breath Therapeutics
Exited 2019
BiotechGermany· 2016
to
Corvidia Therapeutics
Exited 2020
BiotechUS· 2016
to
Delinia
Exited 2017
BiotechUK· 2016
to
ENYO Pharma
ENYO Pharma
Active
BiotechFrance· 2016
BiovelocITA
Active
BiotechItaly· 2015

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Biocomposites
Biocomposites
Active
TA AssociatesUS
CMR Surgical
CMR Surgical
Active
LightrockUK
Neuromod Devices
Neuromod Devices
Active
Enterprise IrelandIreland
Optos
Exited 2015
Amadeus Capital PartnersUK
to
Paragon Vision Sciences
Paragon Vision Sciences
Active
Summit PartnersUS
Ardos
Active
Delphinus Venture CapitalDenmark· 2026
Track ReCor Medical

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on ReCor Medical.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue